Recruiting nowN/AAges 18 Years and up
Blood and Tissue Extraction for Immunological Examinations During Neoadjuvant Therapy of Soft Tissue Sarcomas
Sponsor: University Hospital Tuebingen · NCT06385288 on ClinicalTrials.gov ↗
Conditions studied
Soft Tissue Sarcoma Adult
What it tests
- Blood and tissue collection for immunological studies, advanced imaging.other
- neoadjuvant Therapyother
Where it's running1 site
1 international site
- Recruiting now
University Hospital Tuebingen
Tübingen, Baden-Wurttemberg, Germany 72076
- Vlatko Potkrajcic, MD(contact)+49 7071 29[email protected]
- Cihan Gani, MD(contact)+49 7071 29[email protected]
See the official eligibility language
Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.
Inclusion Criteria: * Planned histological confirmation for especially high-risk soft tissue sarcoma via open Sampling * Indication for neoadjuvant multimodal therapy (radiation and locoregional Hyperthermia, optionally with simultaneous chemotherapy) * Planned resection of a department of the CWS * Age \> 18 years * Ability to consent * Additionally for imaging study: Treatment on the combined MR hyperthermia device Exclusion Criteria: * Age \< 18 years * Poor understanding (language etc.) * Lack of reconnaissance ability
Updated 2024-12-06 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.